栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/06 | 2,350 | 2,351 | 2,289 | 2,300 | -45 | -1.9% | 61,600 |
2018/09/05 | 2,328 | 2,365 | 2,322 | 2,345 | +23 | +1% | 82,200 |
2018/09/04 | 2,320 | 2,335 | 2,307 | 2,322 | +21 | +0.9% | 50,000 |
2018/09/03 | 2,303 | 2,306 | 2,267 | 2,301 | ±0 | ±0% | 57,100 |
2018/08/31 | 2,239 | 2,329 | 2,236 | 2,301 | +59 | +2.6% | 116,900 |
2018/08/30 | 2,241 | 2,270 | 2,239 | 2,242 | -18 | -0.8% | 124,100 |
2018/08/29 | 2,275 | 2,290 | 2,252 | 2,260 | -1 | ±0% | 77,500 |
2018/08/28 | 2,300 | 2,307 | 2,257 | 2,261 | -28 | -1.2% | 76,600 |
2018/08/27 | 2,288 | 2,315 | 2,277 | 2,289 | +6 | +0.3% | 74,100 |
2018/08/24 | 2,300 | 2,307 | 2,274 | 2,283 | +9 | +0.4% | 55,300 |
2018/08/23 | 2,268 | 2,294 | 2,240 | 2,274 | +23 | +1% | 107,000 |
2018/08/22 | 2,201 | 2,255 | 2,201 | 2,251 | +57 | +2.6% | 78,200 |
2018/08/21 | 2,176 | 2,231 | 2,160 | 2,194 | ±0 | ±0% | 80,900 |
2018/08/20 | 2,237 | 2,263 | 2,191 | 2,194 | -33 | -1.5% | 68,200 |
2018/08/17 | 2,196 | 2,235 | 2,196 | 2,227 | +36 | +1.6% | 72,100 |
2018/08/16 | 2,231 | 2,246 | 2,188 | 2,191 | -54 | -2.4% | 77,800 |
2018/08/15 | 2,269 | 2,278 | 2,239 | 2,245 | -24 | -1.1% | 52,200 |
2018/08/14 | 2,212 | 2,270 | 2,212 | 2,269 | +61 | +2.8% | 74,500 |
2018/08/13 | 2,246 | 2,255 | 2,201 | 2,208 | -44 | -2% | 73,100 |
2018/08/10 | 2,282 | 2,299 | 2,249 | 2,252 | -49 | -2.1% | 93,600 |
2018/08/09 | 2,321 | 2,332 | 2,295 | 2,301 | -22 | -0.9% | 82,700 |
2018/08/08 | 2,333 | 2,355 | 2,317 | 2,323 | -14 | -0.6% | 91,700 |
2018/08/07 | 2,337 | 2,368 | 2,324 | 2,337 | +1 | ±0% | 98,000 |
2018/08/06 | 2,386 | 2,399 | 2,330 | 2,336 | -60 | -2.5% | 109,700 |
2018/08/03 | 2,441 | 2,449 | 2,383 | 2,396 | -35 | -1.4% | 86,400 |
2018/08/02 | 2,464 | 2,483 | 2,431 | 2,431 | -38 | -1.5% | 76,800 |
2018/08/01 | 2,465 | 2,485 | 2,460 | 2,469 | +30 | +1.2% | 77,700 |
2018/07/31 | 2,440 | 2,473 | 2,392 | 2,439 | -9 | -0.4% | 221,700 |
2018/07/30 | 2,588 | 2,598 | 2,446 | 2,448 | -167 | -6.4% | 192,900 |
2018/07/27 | 2,696 | 2,700 | 2,551 | 2,615 | -80 | -3% | 467,800 |
2018/07/26 | 2,454 | 2,699 | 2,421 | 2,695 | +309 | +13% | 564,900 |
2018/07/25 | 2,408 | 2,408 | 2,359 | 2,386 | +8 | +0.3% | 168,900 |
2018/07/24 | 2,400 | 2,413 | 2,363 | 2,378 | -9 | -0.4% | 73,500 |
2018/07/23 | 2,369 | 2,403 | 2,351 | 2,387 | -15 | -0.6% | 89,800 |
2018/07/20 | 2,396 | 2,428 | 2,384 | 2,402 | +4 | +0.2% | 56,900 |
2018/07/19 | 2,504 | 2,529 | 2,386 | 2,398 | -109 | -4.3% | 126,100 |
2018/07/18 | 2,459 | 2,517 | 2,459 | 2,507 | +76 | +3.1% | 149,400 |
2018/07/17 | 2,409 | 2,446 | 2,381 | 2,431 | +14 | +0.6% | 106,800 |
2018/07/13 | 2,361 | 2,426 | 2,357 | 2,417 | +56 | +2.4% | 111,200 |
2018/07/12 | 2,352 | 2,435 | 2,349 | 2,361 | +43 | +1.9% | 165,100 |
2018/07/11 | 2,270 | 2,326 | 2,256 | 2,318 | +39 | +1.7% | 123,500 |
2018/07/10 | 2,260 | 2,296 | 2,228 | 2,279 | +26 | +1.2% | 138,200 |
2018/07/09 | 2,220 | 2,259 | 2,190 | 2,253 | +51 | +2.3% | 80,100 |
2018/07/06 | 2,201 | 2,212 | 2,151 | 2,202 | +15 | +0.7% | 114,300 |
2018/07/05 | 2,237 | 2,240 | 2,173 | 2,187 | -48 | -2.1% | 148,700 |
2018/07/04 | 2,181 | 2,257 | 2,167 | 2,235 | +36 | +1.6% | 190,700 |
2018/07/03 | 2,252 | 2,259 | 2,186 | 2,199 | -62 | -2.7% | 157,500 |
2018/07/02 | 2,345 | 2,348 | 2,256 | 2,261 | -96 | -4.1% | 107,600 |
2018/06/29 | 2,385 | 2,385 | 2,304 | 2,357 | -11 | -0.5% | 121,600 |
2018/06/28 | 2,425 | 2,431 | 2,334 | 2,368 | -75 | -3.1% | 148,000 |
1501~
1550
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム